Accelerates Commercialization and Adoption of Transformative Multi-Cancer Screening Test with Potential to Detect More Cancers Earlier and Enable Better Outcomes Adds Multi-Disciplinary Team and Capabilities Harnessing...read more
Latest news and articles
Tempus and LabCorp Announce Collaboration to Accelerate Clinical Trial Patient Participation
CHICAGO & BURLINGTON, N.C.–(BUSINESS WIRE)–Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, and LabCorp (NYSE: LH), a...read more
NanoString Launches Whole Transcriptome Atlas under GeoMx Technology Access Program and Names First GeoMx Premier Access Sites
Whole Transcriptome Atlas Service Based in NanoString’s Seattle Labs Premier Access Sites to Offer the Cancer Transcriptome Atlas Service from Labs Across the Globe SEATTLE–(BUSINESS WIRE)–NanoString...read more
ClinSpec Dx receive £2.4m funding boost
Efforts to improve the early detection of cancer have received a significant boost with a £2.4 million funding deal to support the further development of innovative testing technology. Glasgow-based ClinSpec Diagnostics...read more
Illumina Collaborates With 54gene in the Creation of a World-Class Genomics Facility in Nigeria
Partnership will expand 54gene’s sequencing-based research and molecular diagnostics capabilities with a focus on improving health outcomes through precision medicine CAMBRIDGE, England–(BUSINESS...read more
Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection
Proceeds will accelerate ongoing FDA registrational study of company’s first blood test for colorectal cancer screening and advance product pipeline Freenome will leverage its unique platform that characterizes both...read more
Biofidelity raises $12m in Series A financing to accelerate launch of disruptive cancer diagnostic technology
Supported by BlueYard Capital, Longwall Ventures and Agilent TechnologiesFunds to be used to bring technology to market, enabling a dramatic simplification of precision genetic testing to ensure many more cancer...read more
Mission Bio Raises $70M in Series C Funding Led by Novo Holdings to Accelerate Development of Cancer Therapies with Single-cell Multi-omics
Capital raised will scale the Tapestri Platform to advance the development of precision medicine through improved biomarker discovery and drug development SOUTH SAN FRANCISCO, Calif. (August 13, 2020) Mission Bio, Inc...read more
Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement
WALTHAM, Mass., Aug. 13, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its offer to acquire all of the ordinary shares of...read more
Syapse and FDA Expand Existing Research Collaboration to Rapidly Generate Real-World Data Related to COVID-19 and Cancer
Research collaboration expanding to address urgent public health challenges including supporting FDA’s goal of rapid understanding of COVID-19 SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) — Syapse®, a real-world...read more
